Cargando…
Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the individual patient. Precision public health would lead to the right intervention in each VL endem...
Autor principal: | Zijlstra, Eduard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630745/ https://www.ncbi.nlm.nih.gov/pubmed/34858865 http://dx.doi.org/10.3389/fcimb.2021.707619 |
Ejemplares similares
-
Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in Brazil and Italy
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2022) -
Biomarkers in Post-kala-azar Dermal Leishmaniasis
por: Zijlstra, Eduard E.
Publicado: (2019) -
Leptomonas seymouri Co-infection in Cutaneous Leishmaniasis Cases Caused by Leishmania donovani From Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2020) -
Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020) -
Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)